CEO and Chairman of the Board of Athenex Inc (ATNX, Financial) Johnson Yiu Nam Lau bought 12,000 shares of ATNX on 03/15/2019 at an average price of $11.77 a share. The total cost of this purchase was $141,240.
Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Athenex Inc has a market cap of $795.560 million; its shares were traded at around $11.87 with and P/S ratio of 8.52.
CEO Recent Trades:
- CEO and Chairman of the Board, 10% Owner Johnson Yiu Nam Lau bought 12,000 shares of ATNX stock on 03/15/2019 at the average price of $11.77. The price of the stock has increased by 0.85% since.
- CEO and Chairman of the Board, 10% Owner Johnson Yiu Nam Lau bought 2,814 shares of ATNX stock on 03/12/2019 at the average price of $11.8. The price of the stock has increased by 0.59% since.
- CEO and Chairman of the Board, 10% Owner Johnson Yiu Nam Lau bought 10,000 shares of ATNX stock on 03/11/2019 at the average price of $11.78. The price of the stock has increased by 0.76% since.
Directors and Officers Recent Trades:
- Director Song-yi Zhang sold 120,053 shares of ATNX stock on 03/13/2019 at the average price of $11.88. The price of the stock has decreased by 0.08% since.
- Director Sheldon Trainor-degirolamo sold 45,915 shares of ATNX stock on 03/13/2019 at the average price of $11.77. The price of the stock has increased by 0.85% since.
For the complete insider trading history of ATNX, click here
.
